NCATS Turns to Crowdsourcing | GenomeWeb

The National Center for Advancing Translational Sciences is doling out $12.7 million in new grants to nine academic research teams that will try to come up with new uses for existing compounds that are owned by major pharmaceutical firms.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: proteomic consequences of genomic changes in ovarian cancer, Human SRMAtlas, and more.

At Nature, John Wilbanks and Eric Topol call for openness in health data.

Law.com predicts that genomic and genetic testing will become common in toxic tort cases.

A Pew Research Center report finds that most Americans are wary of using technologies like gene editing to enhance human abilities.